Alyeska Investment Group, L.P. Sarepta Therapeutics, Inc. Transaction History

Alyeska Investment Group, L.P.

$18 Billion
Q3 2024

A detailed history of Alyeska Investment Group, L.P. transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 235,240 shares of SRPT stock, worth $28.7 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares

235,240

Previous 60,000 292.07%

Holding current value

$28.7 Million

Previous $9.48 Million 209.93%

% of portfolio

0.16%

Previous 0.06%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$124.33 - $156.75 $21.8 Million - $27.5 Million	175,240 Added 292.07%	235,240 $29.4 Million
Q2 2024 Aug 14, 2024	BUY	$113.33 - $163.85 $6.8 Million - $9.83 Million	60,000 New	60,000 $9.48 Million
Q2 2023 Aug 14, 2023	BUY	$106.4 - $157.19 $2.97 Million - $4.38 Million	27,869 New	27,869 $3.19 Million
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $23.4 Million - $37.3 Million	-283,659 Reduced 98.37%	4,708 $460,000
Q4 2019 Feb 14, 2020	SELL	$76.53 - $135.58 $14.3 Million - $25.3 Million	-186,887 Reduced 39.32%	288,367 $37.2 Million
Q3 2019 Nov 14, 2019	BUY	$72.81 - $156.91 $6.79 Million - $14.6 Million	93,319 Added 24.43%	475,254 $35.8 Million
Q2 2019 Aug 14, 2019	SELL	$112.21 - $151.95 $2.28 Million - $3.09 Million	-20,357 Reduced 5.06%	381,935 $0
Q1 2019 May 15, 2019	BUY	$106.67 - $151.68 $13.9 Million - $19.7 Million	130,002 Added 47.74%	402,292 $0
Q4 2018 Feb 14, 2019	SELL	$97.32 - $148.76 $9.94 Million - $15.2 Million	-102,092 Reduced 27.27%	272,290 $29.7 Million
Q3 2018 Nov 14, 2018	SELL	$115.31 - $161.51 $9.09 Million - $12.7 Million	-78,842 Reduced 17.4%	374,382 $60.5 Million
Q2 2018 Aug 14, 2018	BUY	$71.74 - $153.69 $19.6 Million - $41.9 Million	272,943 Added 151.4%	453,224 $59.9 Million
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $47.1 Million - $71.7 Million	-871,192 Reduced 82.85%	180,281 $13.4 Million
Q4 2017 Feb 14, 2018	BUY	$47.64 - $56.75 $22.8 Million - $27.1 Million	478,033 Added 83.36%	1,051,473 $58.5 Million
Q3 2017 Nov 14, 2017	BUY	$35.73 - $47.15 $20.5 Million - $27 Million	573,440	573,440 $26 Million

Others Institutions Holding SRPT

# of Institutions

529

Shares Held

84.2M

Call Options Held

2.06M

Put Options Held

1.52M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.7B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alyeska Investment Group, L.P. with notifications on news.

Account

Alyeska Investment Group, L.P. Sarepta Therapeutics, Inc. Transaction History